Search Results 1001-1010 of 21607 for Inhibition

1. A Study to Assess Kidney Function Markers in Transgender Individuals Receiving Gender-affirming Hormone Therapy - Mayo Clinic

   5-Alpha Reductase Inhibitor (Finasteride, Dutasteride);; Anti-Androgens (Leuprolide, Bicalutamide, Cyproterone Acetate). Any exclusion criteria by study 20 ...

2. Prostate Cancer Cell Research Suggests Possible Therapy - Mayo Clinic News Network

   Haojie Huang, Ph.D. Bromodomain and extra-terminal domain inhibitors are drugs that prevent the action of BET proteins, an important task because these proteins ...

3. AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - Mayo Clinic

   Any prior treatment with a PARP inhibitor or platinum chemotherapy. ... Strong CYP2C8 inhibitors or inducers (applicable only to enzalutamide combination);.

4. A Study Of Opioid Avoidance In Surgery Through Integrating Suzetrigine - Mayo Clinic

   Patients using strong CYP3A4 inhibitor medications (i.e. itraconazole, ketoconazole, clarithromycin, ritonavir, and grapefruit juice). Known allergy to ...

5. Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM) - Mayo Clinic

   patients are intolerable to such agents or ineligible to receive such agents. - At least triple-class refractory (refractory to a proteasome inhibitor, ...

6. Moclobemide (oral route) - Side effects & dosage - Mayo Clinic

   Moclobemide is a monoamine oxidase (MAO) inhibitor used to treat certain types of mental depression. It works by blocking the action of a chemical substance ...

7. Synthetic THC And Blood Pressure - Mayo Clinic

   Prescribed CYP2C9 and/or CYP3A4 inhibitors. History of shift work or rotating shifts within 1 month. Note: Other protocol defined Inclusion/Exclusion ...

8. Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer that has been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) - Mayo Clinic

   No prior treatment with crizotinib or another ALK inhibitor; No ongoing ... inhibitors or inducers, included but not limited to those outlined; Patients ...

9. IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Systemic treatment with strong inhibitors of CYP1A2 (fluvoxamine, enoxacin, ciprofloxacin), strong inhibitors of CYP3A (clarithromycin, telithromycin ...

10. Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors - Mayo Clinic

    No prior treatment with an inhibitor of vascular endothelial growth ... inhibitors must discontinue the drug 14 days prior to the start of study treatment ...